ASTERDM NSE filing

Aster DM Healthcare publishes audited financial results for Q4FY26

The RealCase readLow impact Neutral

Aster DM Healthcare Limited announced its audited standalone and consolidated financial results for the quarter and year ended March 31, 2026. The results were approved by the Board on April 30, 2026, and audited by Deloitte Haskins & Sells. Full details are available on the company and stock exchange websites.

Why it matters

This is a standard financial results disclosure, which is expected from publicly listed companies. It does not contain any significant new information that would drastically impact the company's stock or operations.

The market read

The announcement is a routine disclosure of financial results and does not contain any exceptionally positive or negative news.

Aster DM Healthcare Limited has announced its audited standalone and consolidated financial results for the quarter and year ended March 31, 2026. The Board of Directors approved these results on April 30, 2026, following a review by the Audit Committee. The financial results have been audited by Deloitte Haskins & Sells, the company's statutory auditors. The detailed financial results, along with the auditors' reports, are available on the websites of the BSE (www.bseindia.com) and NSE (www.nseindia.com), as well as on the company's website at https://www.asterdmhealthcare.in/investors/financial-information/quarterly-reports. The company has also provided a Quick Response (QR) code for accessing these results. The announcement was published in the Financial Express newspaper on May 1, 2026. The company's registered office is located at No 7-1-450/20, Plot No-04, Mythri Vihar, Sanjeev Reddy Nagar, Hyderabad, Telangana, India -500038, and its corporate office is at Awfis, 2nd Floor, Renaissance Centra, 27 & 27/1, Mission Road, Sampangi Rama Nagar, Bengaluru, Karnataka, India -560027.

Filing to action

What to do with a filing like this

Aster DM Healthcare Limited filed this with the NSE as a statutory disclosure, categorised under quarterly results. It is a primary document, not a recommendation, and the desk marks it low impact, the band that almost never moves a portfolio on its own.

That call is the part a filing cannot make for you. On RealCase, SEBI-registered research analysts and investment advisers read announcements like this one and turn the ones that matter into actions inside their model portfolios: a change in weight, a hold, or nothing at all. You are not left working out which of the roughly 250 filings published each day needs a response. The portfolio you follow is updated when a filing actually warrants it, with the reason written down.

See the model portfolios
Primary source

A plain-language summary of a public exchange filing by Aster DM Healthcare Limited. Read the original for the full detail.

View original filing